Retinitis Pigmentosa in Indonesia Archives - Eye Stem Cell Center

Patients in Indonesia facing vision loss due to retinal and optic nerve conditions are increasingly exploring stem cell therapy as an advanced treatment option. Eye diseases such as Retinitis Pigmentosa, optic nerve damage, and macular degeneration can gradually reduce vision and impact everyday activities. When conventional treatments offer limited improvement, regenerative medicine provides a new

Indonesia is witnessing a growing number of patients diagnosed with inherited and degenerative eye diseases, particularly among aging populations and individuals with genetic retinal conditions. Disorders such as Retinitis Pigmentosa, Leber Hereditary Optic Neuropathy (LHON), optic nerve atrophy, and cone-rod dystrophy can progressively impair vision, reducing independence and overall quality of life. As medical awareness

Optic Nerve Atrophy (ONA) is a serious eye condition that leads to damage or degeneration of the optical nerve, performing in partial or complete vision loss. In recent times, Optic Nerve Atrophy in Indonesia has come an area of growing concern as further people are diagnosed with visual impairment caused by nerve damage due to

Retinitis Pigmentosa (RP) is a group of rare, inherited eye  diseases that affect the retina’s capability to respond to light. It causes a gradational loss of vision,  frequently beginning with night blindness and progressing to lair vision or indeed complete blindness over time. In Indonesia, where access to technical eye care can vary significantly between